Concepedia

Vishal Didwania

VD

5

Publications

126

Citations

5

H-Index

2020

Active since

Affiliations

Infectious Disease Consultants(Current)

Vishal Didwania is an author at Infectious Disease Consultants specializing in immunology, clinical microbiology, and medicine.

Top concepts

Covid-19MedicineImmunologyImmunotherapyClinical MicrobiologySepsisIntensive CareEmergency MedicineClinical EpidemiologyMechanical Ventilation

Publications per year

2020–2021

5

Publications

5

Treatment of Acute Osteomyelitis with Once-Weekly Oritavancin: A Two-Year, Multicenter, Retrospective Study

Nicholas W. Van Hise, Vishnu Chundi, Vishal Didwania et al. · Drugs - Real World Outcomes · 2020 · 41 citations · Full text

A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline

Nicholas Van Hise, Russell M. Petrak, Nathan C. Skorodin et al. · Infectious Diseases and Therapy · 2020 · 29 citations · Full text

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2

Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise et al. · Clinical and Translational Science · 2020 · 22 citations · Full text

Il-6 Receptor Antagonist, Acute Care, Immunology +13

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2

Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise et al. · 2020 · 19 citations · Full text

Immunology, Early Dosing, Antiviral Drug +17

Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2

Russell M. Petrak, Nicholas W. Van Hise, Nathan C. Skorodin et al. · Critical Care Explorations · 2021 · 15 citations · Full text

Rows per page

1–5 of 5